Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

15.50
Delayed Data
As of Jun 24
 -0.58 / -3.61%
Today’s Change
14.07
Today|||52-Week Range
18.04
-4.32%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close16.08
Today’s open15.50
Day’s range15.40 - 15.66
Volume1,800,772
Average volume (3 months)1,373,142
Market cap$4.1B
Dividend yield2.29%
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.80%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.31-2.94%
ICPTIntercept Pharmaceut...-11.34-7.35%
ACADACADIA Pharmaceutica...-2.07-6.18%
ANACAnacor Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs